missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human FGFR3 (IIIc) Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 766-FR-050
4042.22 NOK valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Human FGF R3 (IIIc) Fc Chimera Protein is derived from NS0. The Recombinant Human FGF R3 (IIIc) Fc Chimera Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 64.7 kDa (monomer) | |
| 50μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| <0.1 EU per 1μg of the protein by the LAL method. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 2261 | |
| FGFR3 | |
| Mouse myeloma cell line,NS0-derived human FGF R3 protein, (N-terminus) Human FGF R3 (IIIc) (Glu23-Gly375) Accession &Num; P22607 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| CD333, CEK, EC 2.7.10, FGF R3, fibroblast growth factor receptor 3, HSFGFR3EX, JTK4, JTK4thanatophoric dwarfism | |
| Recombinant |